Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK Pfizer has enlisted McCann HumanCare to help launch Chantix, a new prescription smoking-cessation drug, the agency said today.
Chantix will debut later this year. Estimated media spending is $75 million, according to sources.
McCann HumanCare is the health and wellness arm of Interpublic Group’s McCann Erickson in New York.
The account was awarded after a review in which at least two other undisclosed agencies participated.
In a statement, Andrew Shirmer, managing director of McCann HumanCare, said, “We are delighted with the huge opportunity to help people quit smoking and help market Chantix.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in